WOC2012


Go to content

Amico_IES-GLA-SU21

Program

 

 


Minimally Invasive Glaucoma Surgery - Updates on Combined Trabectome with Cataract and Trabectome Alone

Evening Symposium

Sponsored by : AMICO

IES-GLA-SU 21

17:15 - 18:15

Hall 02

Minimally Invasive Glaucoma Surgery - Updates on Combined Trabectome with

 

Cataract and Trabectome Alone

 

Speaker

George Baerveldt

 

Abstract

Purpose: To compare the outcome of Trabectome surgery alone vs. Trabectome combined with phacoemulsification. Methods: This study was a prospective, multi-center, nonrandomized, comparative cohort study of 3222 patients that underwent Trabectome alone (n=1963) or Trabectome combined with phacoemulsification (n=1259). The primary outcome measure was the reduction in intraocular pressure (IOP) from baseline. Other
outcomes assessed were the reduction in use of glaucoma medications and the need for additional surgeries.
Results: Trabectome only: The mean pre-operative IOP and IOP Trabectome only surgery group at 12, 24, 36, 48 and 60 months follow-up is 25.58.0, 16.64.0, 17.25.2, 16.95.1, 15.92.8 and 16.12.0 respectively. Average medications pre-op and at 1year,
2years, 3years, 4years and 5 years is 2.891.29, 2.191.36, 2.011.40, 1.821.32, 1.421.18, 1.171.11 respectively. Trabectome combined with Phacoemulsification: The mean preoperative IOP and IOP after surgery at 12, 24, 36 months is 20.66.5, 15.63.6, 15.73.9, 15.73.3 respectively. Average medications preop and at 1 year, 2 years, and 3 years is 2.471.16, 1.661.28, 1.911.31, 1.911.22 respectively.
Conclusion: Trabectome surgery is a minimally invasive glaucoma procedure that is effective in reducing IOP and the need for glaucoma medication when performed alone or combined with phacoemulsification as it can easily be combined with cataract procedure.

   

Back

     
     
     

Back to content | Back to main menu